The programmes mission is centred around improving patient treatment through the optimisation, of current treatments, understanding variability in patient responses from both an efficacy and safety perspective, and formulation of advanced personalised therapeutics, such as gene and cellular therapies.
The programme is led by internationally recognised clinical and non-clinical experts in the field of pharmacology, toxicology, and precision medicine based in the world-renowned Wolfson centre for Personalised Medicine at the University of Liverpool. In addition, teaching will be delivered by experts in the field from the biotechnology and pharma industry.
At the heart of the programme are modules centred around key topics in the field of pharmacology and personalised medicine. Advances in Personalised Healthcare will provide students with learning opportunities in understanding the principle of pharmacogenomics as well as other examples of personalised or stratified healthcare in both clinical and drug development settings. Linked to this is the Experimental Medicine and Clinical Pharmacology module, where students will learn how clinical trials are conducted, and how risk assessment needs to be managed in early phase trials, particularly for these new therapeutic modalities.
*Price shown is for indicative purposes, please
11/07/2025
Start date
September 2025
Liverpool Campus
Foundation Building, Brownlow Hill,
Liverpool,
L69 7ZX, England, United Kingdom
We accept a 2:2 honours degree from a UK university, or an equivalent academic qualification from a similar non-UK institution. This degree should be in a Biological Sciences subject or equivalent. Candidates must have a scientific background acceptable to the Programme Director. IELTS: 6.5 overall, with no component below 6.0. TOEFL iBT: 88 overall, with minimum scores of listening 19, writing 19, reading 19 and speaking 20. TOEFL Home Edition not accepted.
*There may be different IELTS requirements depending on your chosen course.
The University of Liverpool is the original redbrick university. A world leader with 8,000 international students from over 130 countries.